P-TEFb: The master regulator of transcription elongation
K Fujinaga, F Huang, BM Peterlin - Molecular cell, 2023 - cell.com
The positive transcription elongation factor b (P-TEFb) is composed of cyclins T1 or T2 and
cyclin-dependent kinase 9 that regulate the elongation phase of transcription by RNA …
cyclin-dependent kinase 9 that regulate the elongation phase of transcription by RNA …
CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents
AT Anshabo, R Milne, S Wang, H Albrecht - Frontiers in oncology, 2021 - frontiersin.org
Cyclin-dependent kinases (CDKs) are proteins pivotal to a wide range of cellular functions,
most importantly cell division and transcription, and their dysregulations have been …
most importantly cell division and transcription, and their dysregulations have been …
Mammalian cyclin-dependent kinases
M Malumbres, M Barbacid - Trends in biochemical sciences, 2005 - cell.com
Cyclin-dependent kinases (Cdks) are the catalytic subunits of a family of mammalian
heterodimeric serine/threonine kinases that have been implicated in the control of cell-cycle …
heterodimeric serine/threonine kinases that have been implicated in the control of cell-cycle …
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
JH Choi, AS Banks, TM Kamenecka, SA Busby… - Nature, 2011 - nature.com
PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs
including rosiglitazone and pioglitazone. These drugs are full classical agonists for this …
including rosiglitazone and pioglitazone. These drugs are full classical agonists for this …
Controlling the elongation phase of transcription with P-TEFb
BM Peterlin, DH Price - Molecular cell, 2006 - cell.com
The positive transcription elongation factor b (P-TEFb) is a cyclin-dependent kinase that
controls the elongation phase of transcription by RNA polymerase II (RNAPII). This process …
controls the elongation phase of transcription by RNA polymerase II (RNAPII). This process …
Targeting CDK9 for anti-cancer therapeutics
R Mandal, S Becker, K Strebhardt - Cancers, 2021 - mdpi.com
Simple Summary CDK9, in combination with Cyclin T1, is one of the major regulators of RNA
Polymerase II mediated productive transcription of critical genes in any cell. The activity of …
Polymerase II mediated productive transcription of critical genes in any cell. The activity of …
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro
Y Zhu, T Pe'ery, J Peng, Y Ramanathan… - Genes & …, 1997 - genesdev.cshlp.org
P-TEFb is a key regulator of the process controlling the processivity of RNA polymerase II
and possesses a kinase activity that can phosphorylate the carboxy-terminal domain of the …
and possesses a kinase activity that can phosphorylate the carboxy-terminal domain of the …
P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
DH Price - Molecular and cellular biology, 2000 - Am Soc Microbiol
The elongation phase of transcription by RNA polymerase II is one of the many steps during
the generation of mature mRNAs that is subject to regulation. Shortly after initiation, RNA …
the generation of mature mRNAs that is subject to regulation. Shortly after initiation, RNA …
Overview of CDK9 as a target in cancer research
F Morales, A Giordano - Cell Cycle, 2016 - Taylor & Francis
ABSTRACT CDK9 is a protein in constant development in cancer therapy. Herein we
present an overview of the enzyme as a target for cancer therapy. We provide data on its …
present an overview of the enzyme as a target for cancer therapy. We provide data on its …
Identification of multiple cyclin subunits of human P-TEFb
The transition from abortive into productive elongation is proposed to be controlled by a
positive transcription elongation factor b (P-TEFb) through phosphorylation of the carboxy …
positive transcription elongation factor b (P-TEFb) through phosphorylation of the carboxy …